Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 14 of 14 entries
View as:

V-Boost Immunotherapy in Glioblastoma Multiforme Brain Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03916757 Org: User:
Start: 04/16/19 End: 06/15/20 Due: 06/15/21

Open Label Immunotherapy Trial of Inoperable Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03165591 Org: User:
Start: 05/01/17 End: 12/31/20 Due: 12/31/21

Open Label Immunotherapy of Myoma

Phase: N/A Priority: Normal
NCT ID: NCT03550703 Org: User:
Start: 06/01/18 End: 12/31/19 Due: 12/31/20

Immunotherapy of Cervical Cancer With V3-Cervix

Phase: N/A Priority: Normal
NCT ID: NCT03550755 Org: User:
Start: 07/01/18 End: 12/31/19 Due: 12/31/20

Open Label Trial of Immunotherapy for Advanced Liver Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02256514 Org: User:
Start: 09/30/14 End: 12/31/19 Due: 12/31/20

Tableted COVID-19 Therapeutic Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT04380532 Org: User:
Start: 05/15/20 End: 06/15/21 Due: 06/15/22

TB Immunotherapy Trial With Heat-killed M. Vaccae

Phase: N/A Priority: Normal
NCT ID: NCT01977768 Org: User:
Start: 03/31/14 End: 12/31/18 Due: 12/31/19

Open Label Immunotherapy Trial for Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03556566 Org: User:
Start: 07/01/18 End: 12/31/19 Due: 12/31/20

Open Label Immunotherapy of Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT03340324 Org: User:
Start: 10/01/17 End: 12/01/19 Due: 12/01/20

Trial of Therapeutic Vaccine in Patients With Cholangiocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03042182 Org: User:
Start: 02/20/17 End: 04/20/20 Due: 04/20/21

Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L

Phase: N/A Priority: Normal
NCT ID: NCT02232490 Org: User:
Start: 01/31/15 End: 12/31/19 Due: 12/31/20

Immunotherapy of Chronic Kidney Failure

Phase: N/A Priority: Normal
NCT ID: NCT04377243 Org: User:
Start: 06/16/20 End: 09/01/21 Due: 09/01/22

Vaccine Against Atherosclerosis in Patients With Overweight Problems or Obesity

Phase: N/A Priority: Normal
NCT ID: NCT03042741 Org: User:
Start: 02/01/17 End: 12/18/19 Due: 12/18/20

Open Label Immunotherapy Trial for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03572361 Org: User:
Start: 07/01/18 End: 12/31/19 Due: 12/31/20